Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference Transcript
Hello, everyone. Thank you for joining us today. My name is Erin Wright. I am Morgan Stanley's Healthcare Services and distribution analyst. I'm pleased to have Elanco CEO, Jeff Simmons with us here today. Elanco is one of those largest animal health pharmaceutical companies globally, and we're looking forward to their comments.
For important disclosures, please see the Morgan Stanley research disclosure website at [morganstanley.com/researchdisclosures]. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, thanks again, Jeff, for coming. And I will turn it over to you for some introductory remarks.
Yes. Okay. Thanks, Erin. Thanks for all you do, and I think you've been probably the leading analyst study in this Animal Health business for a lot of years. So thank you and to Morgan Stanley as well. And I would say the same, look to our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |